Biogen BIIB Ratios (2009-2026)

NASDAQ BIIB
$222.82 -3.06 (-1.35%)
At close: Oct 1, 2026 · 4:00 PM EDT
Reported Financials

Biogen Quarterly Ratios

Periods 70 quarters
Latest Jun 2026

Biogen reported a gross margin of 71.60% and a net margin of 3.56% for the quarter ended Jun 2026. These financial ratios cover 70 quarters of results from Mar 2009 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Ratios Mar2009 Jun2009 Sep2009 Dec2009 Mar2010 Jun2010 Sep2010 Dec2010 Mar2011 Jun2011 Sep2011 Dec2011 Mar2012 Jun2012 Sep2012 Dec2012 Mar2013 Jun2013 Sep2013 Dec2013 Mar2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Profitability
Gross Margin
81.58%75.85%70.22%81.31%81.28%77.56%73.09%75.87%73.93%74.09%76.33%77.85%74.10%76.23%74.11%77.13%73.39%78.26%73.32%71.60%
EBT Margin
10.48%14.81%13.72%49.03%54.66%23.73%17.80%28.83%-5.58%12.22%20.29%28.35%18.29%11.88%12.80%28.12%21.99%-2.46%15.24%4.84%
EBIT Margin
28.57%21.48%24.12%30.34%35.94%1.29%-9.11%4.70%-31.65%-13.69%-3.38%6.19%-7.61%-11.90%-13.09%5.25%-4.62%-24.19%-11.43%-23.56%
EBITDA Margin
33.37%26.40%29.77%35.55%40.75%6.00%-4.56%9.48%-26.71%-7.82%3.06%12.64%-0.20%-4.40%-5.55%12.60%3.36%-15.41%-3.18%-14.93%
Operating Margin
28.57%21.48%24.12%30.34%35.94%1.29%-9.11%4.70%-31.65%-13.69%-3.38%6.19%-7.61%-11.90%-13.09%5.25%-4.62%-24.19%-11.43%-23.56%
Net Margin
11.85%13.47%12.00%40.86%45.23%21.64%15.75%24.09%-2.69%10.46%17.18%23.68%15.76%10.86%9.89%24.00%18.40%-2.15%12.89%3.56%
FCF Margin
27.47%28.78%4.10%27.02%23.99%-10.28%15.78%16.94%20.48%-2.21%22.15%24.03%36.52%29.40%9.14%5.08%48.38%20.53%23.98%14.91%
Efficiency
Inventory AverageInventory Avg.
1.30B1.35B1.28B1.25B1.33B1.36B1.31B1.31B2.16B2.75B2.52B2.51B2.49B2.46B2.37B2.27B2.24B2.19B2.06B2.17B
Assets AverageAssets Avg.
24.14B23.84B23.75B24.35B24.97B24.70B24.58B24.88B26.68B27.52B26.71B26.69B27.56B28.18B28.04B28.18B28.77B29.32B29.46B30.78B
Equity AverageEquity Avg.
11.05B10.92B11.09B11.54B12.32B13.08B13.59B14.12B14.47B14.64B15.01B15.55B16.12B16.54B16.85B17.31B17.92B18.23B18.45B18.75B
Invested CapitalInvested Cap.
11.88B12.96B12.22B12.86B12.77B19.67B14.98B21.89B15.46B15.89B18.11B24.76B18.73B17.63B18.21B24.54B19.65B
Asset Utilization RatioAsset Util.
0.460.460.460.440.420.410.410.400.370.360.360.360.350.340.350.350.350.340.340.33
Leverage & Solvency
Debt Ratio
0.040.080.040.040.260.020.260.010.060.290.060.210.02
Dividends & Payouts
Dividend Coverage RatioDiv. Cover
FCF Payout RatioFCF Cover
Dividend YieldDiv. Yield
Payout Ratio
Valuation
Price to EarningsP/E
26.8922.6621.2814.3713.4213.0912.8515.4825.4832.2926.9129.1417.4913.6613.5512.0312.7819.9819.7338.25
Price to SalesP/S
3.743.212.852.783.713.923.984.143.733.813.253.492.942.302.041.842.042.612.723.18
Price to BookP/B
3.823.222.752.493.012.982.922.852.572.532.062.131.731.331.181.041.131.421.451.69
Enterprise Value
39.07B31.53B27.07B24.79B33.53B34.97B35.19B35.17B34.95B36.45B30.32B31.86B26.55B19.92B17.45B15.65B16.59B22.02B22.78B30.64B
EV to EBIT
20.3211.1010.938.9211.6215.0123.5342.61
EV to EBITDA
16.389.479.017.469.8112.2817.7527.14139.5774.11273.55183.0994.53
Market Capitalization
41.57B35.27B30.84B29.59B38.45B39.88B40.24B41.25B37.24B37.50B31.40B33.77B28.25B22.30B20.05B18.41B20.55B25.84B27.07B31.92B
Price to FCFP/FCF
19.4110.4310.9812.5717.5434.8628.1736.0235.0829.5222.6121.5814.508.198.239.318.9212.6011.1711.84
EV to FCF
18.249.329.6410.5315.3030.5724.6330.7132.9228.6921.8320.3613.637.327.167.917.2010.749.4011.36
EV to CFO
16.058.668.939.7513.9825.2620.9724.6225.7023.5618.4317.8612.486.936.767.406.769.998.7910.64
Return Ratios
Return on Sales [ROS]ROS
28.57%21.48%24.12%30.34%35.94%1.29%-9.11%4.70%-31.65%-13.69%-3.38%6.19%-7.61%-11.90%-13.09%5.25%-4.62%-24.19%-11.43%-23.56%
Return on Capital Employed [ROCE]ROCE
9.65%14.54%12.51%14.37%13.71%10.88%6.94%3.81%-4.05%-5.13%-4.64%-4.46%-1.98%-1.79%-2.84%-2.64%-2.31%-3.26%-3.07%-5.94%
Return on Invested Capital [ROIC]ROIC
22.19%18.06%14.87%15.73%11.84%-6.01%-5.15%-5.91%-2.19%-1.62%-2.50%-3.08%-2.77%-3.29%
Return on Assets [ROA]ROA
8.72%7.25%6.49%6.47%9.58%11.99%12.74%10.71%5.48%4.22%4.37%4.34%5.86%5.79%5.28%5.43%5.59%4.41%4.66%2.71%
Return on Equity [ROE]ROE
19.06%15.82%13.90%13.64%19.42%22.65%23.04%18.87%10.10%7.93%7.78%7.44%10.01%9.87%8.78%8.84%8.98%7.09%7.43%4.45%

Biogen Ratios API

Pull Biogen's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=BIIB&statement=Ratios&frequency=Quarter&period=all&api_key=YOUR_API_KEY